Medical Weight Loss for Altoona, Pennsylvania Residents
Altoona, Pennsylvania residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Altoona through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Altoona Residents Choose New Hope Weight Loss
Altoona patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Pennsylvania and beyond since 2020.
Altoona is served through telehealth from our Costa Mesa, California clinic. The full physician-supervised GLP-1 program runs by secure video, with compounded medication shipped to your Altoona address.
Altoona is served entirely by telehealth, so there is no local office to visit and no waiting room. We care for patients throughout downtown Altoona and the greater Blair County area of central Pennsylvania. Every prescription for Altoona is authorized by Dr. Sharma after reviewing your history, and follow-up continues by video throughout the program.
Our telehealth model serves Altoona and communities across Pennsylvania with the same flat pricing and the same supervising physician. Compounded medication arrives in discreet, cold-pack packaging at your Altoona address, usually within days.
GLP-1 Weight Loss Programs Available
Compounded semaglutide, from $166/mo (90-day program $499)
The 90-day Metabolic Reset is our most-chosen plan. Semaglutide shares its active ingredient with Wegovy® and Ozempic®; in trials of the branded drug, patients lost an average of 15-17% of body weight under physician supervision.
Compounded tirzepatide, from $233/mo
Tirzepatide's dual GLP-1/GIP action reached up to 22.5% body-weight loss in trials of the branded medication, the advanced option for Altoona patients.
The physician review is a flat $119, with medication billed separately; HSA, FSA, Klarna, and Affirm are accepted.
How Telehealth Works for Altoona
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Altoona address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Altoona
How do I get treatment from Altoona?
As a Altoona, Pennsylvania patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Altoona?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Altoona in cold-pack packaging, no lines and no drive.
How much does it cost for Altoona patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Altoona do you serve?
We serve patients from across Altoona by telehealth, including downtown Altoona and the greater Blair County area of central Pennsylvania.
Are there hidden fees for Altoona patients?
No. Altoona patients pay the same flat, stated pricing: a $119 physician visit, then compounded semaglutide from $166/month or tirzepatide from $233/month with medication billed separately. There is no membership lock-in and no distance surcharge.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Altoona, Pennsylvania by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.